Genomic Predictors Associated With Exceptional Response to Systemic Therapy in Advanced Pancreatic Cancer

CONCLUSION: A lower number of nonsynonymous mutations may correlate with exceptional outcomes in patients with pancreatic cancer. These findings should encourage future studies into genomic signatures of exceptional response.PMID:38133563 | DOI:10.46883/2023.25921008

Source: Oncology (Williston Park, N.Y.) - December 22, 2023 Category: Cancer & Oncology Authors: Suneel Kamath Joanna Roopkumar Ying Ni Minqian Shen Pablo Bejarano Daniela Allende Arun Nagarajan Tim Nguyen Bachar Dergham Dale Shepard Marc A Shapiro Michael J McNamara Bassam N Estfan Kanika G Nair Alok A Khorana Source Type: research